Immunotherapies could target aggressive pancreatic cancer, research indicates
The Pharma Data
SEPTEMBER 3, 2020
Comparing four separate forms of the disease, they found that samples of the most aggressive form, known as metastases-like primary tumours, saw changes in activity of 74 immune-related genes, compared with changes in only 12 in the more benign insulinoma-like tumours.
52 
Let's personalize your content